Zai Lab shows strong growth in oncology/autoimmune drugs; reduced losses and efficient operations evident in Q3 results. Healthy financial status with a strong current ratio of 7.68; reduced R&D ...
As we look ahead to 2025, a number of factors poise the clinical laboratory market for continued transformation. The post-COVID-19 landscape is reshaping the industry, presenting both challenges and ...
Rocket Lab is evolving into a vertically integrated space systems leader, with rapid revenue growth and a strong launch cadence fueling its stock surge. The company’s affordable Electron rocket, ...
Rocket Lab is on track for 'a similarly aggressive growth trajectory as SpaceX,' writes KeyBanc Capital Markets analyst Michael Leshock Rocket Lab USA Inc.'s stock initially tumbled in the wake of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback